Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2009 Jul 9;361(2):152-60.
doi: 10.1056/NEJMoa0803783.

Lack of association between folate-receptor autoantibodies and neural-tube defects

Anne M Molloy  1 , Edward V Quadros, Jeffrey M Sequeira, James F Troendle, John M Scott, Peadar N Kirke, James L Mills
Affiliations
Comment

Lack of association between folate-receptor autoantibodies and neural-tube defects

Anne M Molloy et al. N Engl J Med. .

Abstract

Background: A previous report described the presence of autoantibodies against folate receptors in 75% of serum samples from women with a history of pregnancy complicated by a neural-tube defect, as compared with 10% of controls. We sought to confirm this finding in an Irish population, which traditionally has had a high prevalence of neural-tube defects.

Methods: We performed two studies. Study 1 consisted of analysis of stored frozen blood samples collected from 1993 through 1994 from 103 mothers with a history of pregnancy complicated by a neural-tube defect (case mothers), 103 mothers with a history of pregnancy but no complication by a neural-tube defect (matched with regard to number of pregnancies and sampling dates), 58 women who had never been pregnant, and 36 men. Study 2, conducted to confirm that the storage of samples did not influence the folate-receptor autoantibodies, included fresh samples from 37 case mothers, 22 control mothers, 10 women who had never been pregnant, and 9 men. All samples were assayed for blocking and binding autoantibodies against folate receptors.

Results: In Study 1, blocking autoantibodies were found in 17% of case mothers, as compared with 13% of control mothers (odds ratio, 1.54; 95% confidence interval [CI], 0.70 to 3.39), and binding autoantibodies in 29%, as compared with 32%, respectively (odds ratio, 0.82; 95% CI, 0.44 to 1.50). Study 2 showed similar results, indicating that sample degradation was unlikely.

Conclusions: The presence and titer of maternal folate-receptor autoantibodies were not significantly associated with a neural-tube defect-affected pregnancy in this Irish population.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Titers of Folate-Receptor Blocking and Binding Autoantibodies, According to Subject Group and Study
Data for the blocking antibodies are shown in Panel A, and data for the binding antibodies in Panel B.
See this image and copyright information in PMC

Comment on

References

    1. Tamura T, Picciano MF. Folate and human reproduction. Am J Clin Nutr. 2006;83:993–1016. - PubMed
    1. Rothenberg SP, da Costa MP, Sequeira JM, et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med. 2004;350:134–42. - PubMed
    1. Cabrera RM, Shaw GM, Ballard JL, et al. Autoantibodies to folate receptor during pregnancy and neural tube defect risk. J Reprod Immunol. 2008;79:85–92. - PMC - PubMed
    1. Ramaekers VT, Rothenberg SP, Sequeira JM, et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med. 2005;352:1985–91. - PubMed
    1. Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics. 2007;38:276–81. - PubMed

Publication types